
To review zzso basic principles of follow-up in patients who are in complete zzso following zzso therapy for zzso zzso evaluate the available data on follow-up strategies for zzso cancer, Hodgkin's disease, zzso lymphoma, breast cancer, zzso cancer, small cell and zzso cell lung cancer, and prostate zzso and zzso analyze the cost of follow-up zzso 

The English language literature was reviewed utilizing zzso zzso for the specific zzso and the text word zzso zzso of relevant articles also were zzso zzso was placed on zzso zzso trials of large retrospective studies in which all patients who potentially could have been evaluated were zzso The cost of various testing strategies were analyzed utilizing data from the Health Care Finance zzso 

Proper follow-up strategies should take into account patterns and time course of recurrence and should be obtained of detection of recurrence would allow meaningful therapeutic zzso Testing also should be directed at early detection of zzso and zzso complications known to be associated with the primary zzso zzso cancer is a zzso zzso in that sensitive tests for recurrence are available and early detection of recurrence allows for potentially zzso zzso 

According to the currently available literature, repetitive follow-up laboratory and zzso testing, except for zzso germ cell tumors, does not detect the vast majority of cancer zzso nor does it result in a greater chance of cure or prolonged zzso The majority of zzso at all disease sites will first be recognized as symptomatic changes in the patient's condition or zzso in the physical zzso A limited panel of blood tests and zzso studies to detect zzso zzso disease, and complications of therapy zzso and zzso will suffice for most zzso Though data are zzso this more restrictive policy of follow-up testing does not appear to adversely impact patient quality of life and result in dramatic cost of savings to the health care zzso 

